BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 23688022)

  • 1. X-ray irradiation promotes apoptosis of hippocampal neurons through up-regulation of Cdk5 and p25.
    Sun AM; Li CG; Han YQ; Liu QL; Xia Q; Yuan YW
    Cancer Cell Int; 2013 May; 13(1):47. PubMed ID: 23688022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [p35 and p25 expressions and Cdk5 kinase activity in primary cultured rat hippocampal neurons with X-ray exposure].
    Han YQ; Sun AM; Liu QL; Chen LH; Yuan YW
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Mar; 29(3):405-7. PubMed ID: 19304511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calpain-2/p35-p25/Cdk5 pathway is involved in the neuronal apoptosis induced by polybrominated diphenyl ether-153.
    Zhang H; Chang L; Zhang H; Nie J; Zhang Z; Yang X; Vuong AM; Wang Z; Chen A; Niu Q
    Toxicol Lett; 2017 Aug; 277():41-53. PubMed ID: 28559121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 24-residue peptide (p5), derived from p35, the Cdk5 neuronal activator, specifically inhibits Cdk5-p25 hyperactivity and tau hyperphosphorylation.
    Zheng YL; Amin ND; Hu YF; Rudrabhatla P; Shukla V; Kanungo J; Kesavapany S; Grant P; Albers W; Pant HC
    J Biol Chem; 2010 Oct; 285(44):34202-12. PubMed ID: 20720012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p25/CDK5 is partially involved in neuronal injury induced by radiofrequency electromagnetic field exposure.
    Zhang Y; She F; Li L; Chen C; Xu S; Luo X; Li M; He M; Yu Z
    Int J Radiat Biol; 2013 Nov; 89(11):976-84. PubMed ID: 23786497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of Cdk5/p25 and tau phosphorylation following chronic brain hypoperfusion in rats involves microRNA-195 down-regulation.
    Sun LH; Ban T; Liu CD; Chen QX; Wang X; Yan ML; Hu XL; Su XL; Bao YN; Sun LL; Zhao LJ; Pei SC; Jiang XM; Zong DK; Ai J
    J Neurochem; 2015 Sep; 134(6):1139-51. PubMed ID: 26118667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deregulation of cdk5 in Hippocampal sclerosis.
    Sen A; Thom M; Martinian L; Jacobs T; Nikolic M; Sisodiya SM
    J Neuropathol Exp Neurol; 2006 Jan; 65(1):55-66. PubMed ID: 16410749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down-regulation of cyclin-dependent kinase 5 attenuates p53-dependent apoptosis of hippocampal CA1 pyramidal neurons following transient cerebral ischemia.
    Shin BN; Kim DW; Kim IH; Park JH; Ahn JH; Kang IJ; Lee YL; Lee CH; Hwang IK; Kim YM; Ryoo S; Lee TK; Won MH; Lee JC
    Sci Rep; 2019 Sep; 9(1):13032. PubMed ID: 31506563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of aberrant cyclin-dependent kinase 5 activity attenuates isoflurane neurotoxicity in the developing brain.
    Wang WY; Luo Y; Jia LJ; Hu SF; Lou XK; Shen SL; Lu H; Zhang HH; Yang R; Wang H; Ma ZW; Xue QS; Yu BW
    Neuropharmacology; 2014 Feb; 77():90-9. PubMed ID: 24055498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increase of p25 associated with cortical neuronal death induced by hypoxia.
    Huang T; Fang L; Lin Z; Huang E; Ye Q
    Biochem Biophys Res Commun; 2016 Sep; 477(4):932-936. PubMed ID: 27402274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The levels of cdk5 and p35 proteins and tau phosphorylation are reduced during neuronal apoptosis.
    Kerokoski P; Suuronen T; Salminen A; Soininen H; Pirttilä T
    Biochem Biophys Res Commun; 2001 Feb; 280(4):998-1002. PubMed ID: 11162625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of calpain/p35-p25/Cdk5/NMDAR signaling pathway in glutamate-induced neurotoxicity in cultured rat retinal neurons.
    Miao Y; Dong LD; Chen J; Hu XC; Yang XL; Wang Z
    PLoS One; 2012; 7(8):e42318. PubMed ID: 22870316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration.
    Patrick GN; Zukerberg L; Nikolic M; de la Monte S; Dikkes P; Tsai LH
    Nature; 1999 Dec; 402(6762):615-22. PubMed ID: 10604467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of aberrant cyclin-dependent kinase 5/p25 activity in experimental traumatic brain injury.
    Yousuf MA; Tan C; Torres-Altoro MI; Lu FM; Plautz E; Zhang S; Takahashi M; Hernandez A; Kernie SG; Plattner F; Bibb JA
    J Neurochem; 2016 Jul; 138(2):317-27. PubMed ID: 26998748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crosstalk between cdk5 and MEK-ERK signalling upon opioid receptor stimulation leads to upregulation of activator p25 and MEK1 inhibition in rat brain.
    Ramos-Miguel A; GarcĂ­a-Sevilla JA
    Neuroscience; 2012 Jul; 215():17-30. PubMed ID: 22537847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cdk5/p25 specific inhibitory peptide TFP5 rescues the loss of dopaminergic neurons in a sub-acute MPTP induced PD mouse model.
    Zhang Q; Xie H; Ji Z; He R; Xu M; He Y; Huang J; Pan S; Hu Y
    Neurosci Lett; 2016 Oct; 632():1-7. PubMed ID: 27542341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The regulation of cyclin-dependent kinase 5 activity through the metabolism of p35 or p39 Cdk5 activator.
    Hisanaga S; Saito T
    Neurosignals; 2003; 12(4-5):221-9. PubMed ID: 14673209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphorylation of p53 by Cdk5 contributes to benzo[a]pyrene-induced neuronal apoptosis.
    Nie J; Zhang Y; Ning L; Yan Z; Duan L; Xi H; Niu Q; Zhang Q
    Environ Toxicol; 2022 Jan; 37(1):17-27. PubMed ID: 34529316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cdk5/p35 regulates neurotransmitter release through phosphorylation and downregulation of P/Q-type voltage-dependent calcium channel activity.
    Tomizawa K; Ohta J; Matsushita M; Moriwaki A; Li ST; Takei K; Matsui H
    J Neurosci; 2002 Apr; 22(7):2590-7. PubMed ID: 11923424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific inhibition of p25/Cdk5 activity by the Cdk5 inhibitory peptide reduces neurodegeneration in vivo.
    Sundaram JR; Poore CP; Sulaimee NH; Pareek T; Asad AB; Rajkumar R; Cheong WF; Wenk MR; Dawe GS; Chuang KH; Pant HC; Kesavapany S
    J Neurosci; 2013 Jan; 33(1):334-43. PubMed ID: 23283346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.